Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Vascular Dementia Market Grown from 2024 to 2025?

The growth of the vascular dementia market has been swift over the past few years. The market, which is currently valued at $2.92 billion in 2024, is predicted to increase to $3.27 billion in 2025. This demonstrates a compound annual growth rate (CAGR) of 12.1%. Factors such as increased healthcare spending, a surge in diagnosed vascular dementia patients, an increased number of healthcare professionals, growth in public health programs, and a rise in the incidence of diabetes can explain the remarkable growth during the historical period.

What Growth Rate Is Anticipated for the Vascular Dementia Market in the Coming Years?

In the coming years, the market size for vascular dementia is anticipated to expand swiftly, reaching an approximate value of $5.11 billion in 2029 with a compound annual growth rate (CAGR) of 11.8%. This projected growth can be ascribed to several factors such as increasing recognition of vascular dementia, amplified investments in healthcare, the surge in the elderly population, the growing incidence of cardiovascular diseases, and the high occurrence of hypertension. Noteworthy trends for the forecasted period encompass technological advancements, customized care plans, telemedicine, gene therapy, and the integration of artificial intelligence.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

Who Are the Leading Companies in the Vascular Dementia Market?

Major companies operating in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam’s Group of Hospitals, Alpha Cognition Inc., Citi Health

What Are the Key Drivers of the Vascular Dementia Market?

The vascular dementia market continues to be pushed forward by the escalating rates of cardiovascular disease. Cardiovascular ailments include a collection of disorders affecting the heart and blood vessels, amongst them being conditions such as heart failure, hypertension, arrhythmias, and coronary artery disease. The escalating rates can be attributed to several factors, including unhealthy living styles, poor nutrition, physical nonactivity, heightened stress levels, aging demographics, and an increase in risk factors like diabetes, obesity, and hypertension. These diseases heighten the likelihood of vascular dementia by impeding the flow of blood to the brain, ultimately leading to impaired cognitive functioning and damage to the brain cells due to a lack of oxygen and nutrients. For example, data released by the British Heart Foundation, a cardiovascular research charity based in the UK, indicated that nearly 7.6 million people were grappling with heart and circulatory illnesses in September 2024, with an estimated 4 million being males and 3.6 million females. These illnesses account for nearly 27% of all UK fatalities, equating to over 170,000 deaths annually. That’s roughly 480 deaths per day or a death every three minutes. As such, the escalating prevalence of cardiovascular disease bolsters the vascular dementia market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20998&type=smp

What Are the Key Market Segments in the Vascular Dementia Industry?

The vascular dementia market covered in this report is segmented –

1) By Product: Monoclonal Antibodies, Small Molecules, Peptides

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics

Subsegments:

1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies, Anti-Tau Monoclonal Antibodies

2) By Small Molecules: Cholinesterase Inhibitors, Glutamate Modulators, Anti-Inflammatory Small Molecules

3) By Peptides: Amyloid-Beta Targeted Peptides, Neuroprotective Peptides, Tau-Targeting Peptides

What Are the Latest Trends in the Vascular Dementia Market?

Prominent firms active in the vascular dementia market are concentrating on creating innovative therapies like multimodal treatments to maintain their market standing. Multimodal treatments imply the incorporation of a variety of treatment methods such as medication, physical therapy, and psychological strategies, to provide comprehensive care for the afflictions. Take for example, Moleac, a biopharmaceutical organization based in Singapore, unveiled CognivAiD, a highly researched treatment specifically tailored for vascular dementia (VaD), a disease without enough therapeutic alternatives, in January 2023. This medicinal product brings together beneficial extracts from ginkgo, ginseng, and saffron, which have demonstrated substantial effects in slowing down cognitive degeneration in VaD patients. The distinct multimodal approach of CognivAiD addresses vital vascular dementia mechanisms including vascular shielding, vasoregulation, and neuroinflammation. Backed by thorough clinical trials and a robust safety record, CognivAiD offers a promising new therapeutic option for those afflicted with VaD.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

What Are the Key Regional Markets in the Vascular Dementia Industry?

North America was the largest region in the vascular dementia market in 2024. The regions covered in the vascular dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20998

This Report Delivers Insight On:

1. How big is the vascular dementia market, and how is it changing globally?

2. Who are the major companies in the vascular dementia market, and how are they performing?

3. What are the key opportunities and risks in the vascular dementia market right now?

4. Which products or customer segments are growing the most in the vascular dementia market?

5. What factors are helping or slowing down the growth of the vascular dementia market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model